Obagi Nu-Cil® Eyelash Enhancing Serum 3ml
Obagi Nu-Cil® Lash Serum is a clinically proven treatment designed to enhance lash density, thickness and overall definition. Powered by Obagi's NouriPlex® Technology, it delivers targeted nourishment to the lash base, helping to strengthen and condition lashes while supporting a natural, healthy lash cycle.
Results are visible in as little as 8 weeks, with 93% of study participants reporting measurable improvements in lash appearance.* Dermatologically tested and ophthalmologist-reviewed, the serum strengthens lashes while maintaining comfort and safety for sensitive eyes and contact lens wearers.
*Results based on a 2021 16-week blinded study. Data on file at Obagi Cosmeceuticals LLC.
Obagi Nu-Cil® Lash Serum is a clinically proven treatment designed to enhance lash density, thickness and overall definition. Powered by Obagi's NouriPlex® Technology, it delivers targeted nourishment to the lash base, helping to strengthen and condition lashes while supporting a natural, healthy lash cycle.
Results are visible in as little as 8 weeks, with 93% of study participants reporting measurable improvements in lash appearance.* Dermatologically tested and ophthalmologist-reviewed, the serum strengthens lashes while maintaining comfort and safety for sensitive eyes and contact lens wearers.
*Results based on a 2021 16-week blinded study. Data on file at Obagi Cosmeceuticals LLC.
Original: $155.89
-65%$155.89
$54.56Description
Obagi Nu-Cil® Lash Serum is a clinically proven treatment designed to enhance lash density, thickness and overall definition. Powered by Obagi's NouriPlex® Technology, it delivers targeted nourishment to the lash base, helping to strengthen and condition lashes while supporting a natural, healthy lash cycle.
Results are visible in as little as 8 weeks, with 93% of study participants reporting measurable improvements in lash appearance.* Dermatologically tested and ophthalmologist-reviewed, the serum strengthens lashes while maintaining comfort and safety for sensitive eyes and contact lens wearers.
*Results based on a 2021 16-week blinded study. Data on file at Obagi Cosmeceuticals LLC.
